<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Alkermes]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Alkermes on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=182075"/>
<item>
<title><![CDATA[Market Wrap for Wednesday, April 17: Stocks Plunge Again Along With Euro]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/17/market-wrap-for-wednesday-april-17-stocks-plunge-again-along-with-euro/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/17/market-wrap-for-wednesday-april-17-stocks-plunge-again-along-with-euro/</guid>
<pubDate><![CDATA[Wed, 17 Apr 2013 12:27:17 EDT]]></pubDate>
<description><![CDATA[The U.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Health Care Sector Wrap]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/08/20/health-care-sector-wrap/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/08/20/health-care-sector-wrap/</guid>
<pubDate><![CDATA[Mon, 20 Aug 2012 16:51:03 EDT]]></pubDate>
<description><![CDATA[During trading today, both the Health Care sector (XLV) and the S&P500 showed little movement.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Valero Energy, State Street Included in Stocks Up on High Volume Monday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/06/11/valero-energy-state-street-included-in-stocks-up-on-high-volume-monday/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/06/11/valero-energy-state-street-included-in-stocks-up-on-high-volume-monday/</guid>
<pubDate><![CDATA[Mon, 11 Jun 2012 16:33:17 EDT]]></pubDate>
<description><![CDATA[These stocks are up on high volume today: Valero Energy (NYSE:VLO) was up on high volume today, after trading at a volume of 13.4 million, or 1.9 times its average daily volume.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Medco Health Solutions, Express Scripts Included in Stocks Up on High Volume Wednesday]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/03/28/medco-health-solutions-express-scripts-included-in-stocks-up-on-high-volume/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/03/28/medco-health-solutions-express-scripts-included-in-stocks-up-on-high-volume/</guid>
<pubDate><![CDATA[Wed, 28 Mar 2012 12:32:17 EDT]]></pubDate>
<description><![CDATA[Today, these stocks are up on high volume:]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[US Stocks Edge Lower As Europe's Debt Flashpoints Weigh]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/01/30/us-stocks-edge-lower-as-europes-debt-flashpoints-weigh/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/01/30/us-stocks-edge-lower-as-europes-debt-flashpoints-weigh/</guid>
<pubDate><![CDATA[Mon, 30 Jan 2012 17:27:07 EST]]></pubDate>
<description><![CDATA[U.S. stocks edged lower Monday as investors fixed their attention on the standoff between Greece and its private creditors and a surge in Portugal's borrowing costs.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Amylin Rallies 20% On Diabetes Drug Approval]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/01/30/amylin-rallies-20-on-diabetes-drug-approval/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/01/30/amylin-rallies-20-on-diabetes-drug-approval/</guid>
<pubDate><![CDATA[Mon, 30 Jan 2012 11:17:00 EST]]></pubDate>
<description><![CDATA[Shares of Amylin Pharmaceuticals rallied 20% to $14.58 on Friday's news that U.S. regulators have approved its diabetes drug Bydureon.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Alkermes, Amylin Halted As FDA Deadline Approaches]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/01/27/alkermes-amylin-halted-as-fda-deadline-approaches/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/01/27/alkermes-amylin-halted-as-fda-deadline-approaches/</guid>
<pubDate><![CDATA[Fri, 27 Jan 2012 14:17:00 EST]]></pubDate>
<description><![CDATA[Shares of partners Alkermes PLC and Amylin Pharmaceuticals were halted in afternoon trading on Friday.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Alkermes Completes Buy of Elan Drug Technologies]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2011/09/16/alkermes-completes-buy-elan-drug-technologies/?]]></link>
<guid>http://www.foxbusiness.com/markets/2011/09/16/alkermes-completes-buy-elan-drug-technologies/</guid>
<pubDate><![CDATA[Fri, 16 Sep 2011 14:23:36 EDT]]></pubDate>
<description><![CDATA[Pharmaceutical company Alkermes Inc. on Friday completed its merger with Elan Drug Technologies, a drug formulation and manufacturing subsidiary of Elan Corp.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly 1Q Profit Falls 15% Amid Higher Expenses]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2011/04/18/eli-lilly-1q-profit-falls-15-amid-higher-expenses/?]]></link>
<guid>http://www.foxbusiness.com/industries/2011/04/18/eli-lilly-1q-profit-falls-15-amid-higher-expenses/</guid>
<pubDate><![CDATA[Mon, 18 Apr 2011 08:59:29 EDT]]></pubDate>
<description><![CDATA[Eli Lilly said Monday its profits slid by 15% in the first-quarter as the pharmaceutical giant struggled to fend off competition from generic drugs.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Eli Lilly 4Q Profit Jumps 28% On Better Revenue, Margins]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2011/01/27/eli-lilly-q-profit-jumps-better-revenue-margins/?]]></link>
<guid>http://www.foxbusiness.com/markets/2011/01/27/eli-lilly-q-profit-jumps-better-revenue-margins/</guid>
<pubDate><![CDATA[Thu, 27 Jan 2011 10:43:12 EST]]></pubDate>
<description><![CDATA[Eli Lilly & Co.'s (LLY) fourth-quarter earnings rose 28%, topping analysts' views by a penny, as the company said it saw better revenue, helped by higher volume and prices.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Early-Market Movers: Dearborn Bancorp, Tupperware Brands]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/10/20/early-market-movers-dearborn-bancorp-tupperware-brands/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/10/20/early-market-movers-dearborn-bancorp-tupperware-brands/</guid>
<pubDate><![CDATA[Wed, 20 Oct 2010 08:52:51 EDT]]></pubDate>
<description><![CDATA[Here are some early-market movers for Wednesday.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Early Market-Movers: Crucell, Alkermes]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/09/17/early-market-movers-crucell-alkermes/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/09/17/early-market-movers-crucell-alkermes/</guid>
<pubDate><![CDATA[Fri, 17 Sep 2010 09:10:53 EDT]]></pubDate>
<description><![CDATA[Stock futures were pointing to a higher opening following strong earnings from tech companies Oracle (NASDAQ:ORCL) and Research in Motion (NASDAQ:RIMM).]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
